Studies back linagliptin's efficacy in glucose control

10/3/2012 | Healio

Four studies presented at the European Association for the Study of Diabetes meeting showed linagliptin alone or in combination with other diabetes drugs or basal insulin treatment significantly improved blood glucose levels without increasing the risk of hypoglycemia or weight gain in adults and elderly patients with type 2 diabetes. One study also showed linagliptin therapy reduced albuminuria in type 2 diabetes patients with early nephropathy.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Chicago, IL
Senior Manager, Compliance
Fremont, CA
Manager, Business Conduct
Foster City, CA
Product Patent Attorney
Foster City, CA
Employment Counsel
Foster City, CA